相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Marked efficacy of combined three-drug therapy (Sodium Valproate, Topiramate and Stiripentol) in a patient with Dravet syndrome
M. Morimoto et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2018)
Treatment Strategies for Dravet Syndrome
Kelly G. Knupp et al.
CNS DRUGS (2018)
Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study
Kenneth A. Myers et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)
Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes
Iris M. de Lange et al.
EPILEPSIA (2018)
Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center
Giulia S. Porcari et al.
EPILEPSY & BEHAVIOR (2018)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
Orrin Devinsky et al.
NEUROLOGY (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Ketogenic diet effects on 52 children with pharmacoresistant epileptic encephalopathy: A clinical prospective study
Qiong Wu et al.
BRAIN AND BEHAVIOR (2018)
Population Pharmacokinetics of Stiripentol in Paediatric Patients with Dravet Syndrome Treated with Stiripentol, Valproate and Clobazam Combination Therapy
Sophie Peigne et al.
CLINICAL PHARMACOKINETICS (2018)
Sleep problems in Dravet syndrome: a modifiable comorbidity
Shane H. Licheni et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)
Interactions between cannabidiol and commonly used antiepileptic drugs
Tyler E. Gaston et al.
EPILEPSIA (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Rongrui Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel
Elaine C. Wirrell et al.
PEDIATRIC NEUROLOGY (2017)
Parental Perception of Comorbidities in Children With Dravet Syndrome
Kelly G. Knupp et al.
PEDIATRIC NEUROLOGY (2017)
Growth and endocrine function in children with Dravet syndrome
Krista Eschbach et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
Efficacy of adjunctive vagus nerve stimulation in patients with Dravet syndrome: A meta-analysis of 68 patients
Maxine Dibue-Adjei et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
Antiepileptic Drugs in Clinical Development: Differentiate or Die?
Gaetano Zaccara et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Behavioral Comorbidities and Drug Treatments in a Zebrafish scn1lab Model of Dravet Syndrome
Brian P. Grone et al.
ENEURO (2017)
Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient population
An-Sofie Schoonjans et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Photosensitivity in Dravet syndrome is under-recognized and related to prognosis
Nienke Verbeek et al.
CLINICAL NEUROPHYSIOLOGY (2017)
Clemizole and modulators of serotonin signalling suppress seizures in Dravet syndrome
Aliesha Griffin et al.
BRAIN (2017)
Treatment of Dravet Syndrome
Elaine C. Wirrell
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2016)
Palliative epilepsy surgery in Dravet syndrome-case series and review of the literature
Brian J. Dlouhy et al.
CHILDS NERVOUS SYSTEM (2016)
Readthrough-Promoting Drugs Gentamicin and PTC124 Fail to Rescue Nav1.5 Function of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Carrying Nonsense Mutations in the Sodium Channel Gene SCN5A
Georgios Kosmidis et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2016)
Five-year extended follow-up status of 10 patients with Dravet syndrome treated with fenfluramine
Berten Ceulemans et al.
EPILEPSIA (2016)
Disorders of early language development in Dravet syndrome
Daniela Chieffo et al.
EPILEPSY & BEHAVIOR (2016)
Outlining a core neuropsychological phenotype for Dravet syndrome
Domenica Battaglia et al.
EPILEPSY RESEARCH (2016)
Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study
Paola De Liso et al.
EPILEPSY RESEARCH (2016)
Mortality in Dravet syndrome
Monica S. Cooper et al.
EPILEPSY RESEARCH (2016)
Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures
Marcello Venzi et al.
NEUROPHARMACOLOGY (2016)
Proposing a mechanism of action for ataluren
Nadeem Siddiqui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Pitfalls in genetic testing: the story of missed SCN1A mutations
Tania Djemie et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2016)
Seizure precipitants in Dravet syndrome: What events and activities are specifically provocative compared with other epilepsies?
Nienke E. Verbeek et al.
EPILEPSY & BEHAVIOR (2015)
Efficacy and tolerability of the ketogenic diet in Dravet syndrome - Comparison with various standard antiepileptic drug regimen
Anastasia Dressler et al.
EPILEPSY RESEARCH (2015)
Incidence of Dravet Syndrome in a US Population
Yvonne W. Wu et al.
PEDIATRICS (2015)
Pharmacokinetics of Clobazam and N-Desmethylclobazam in Children with Dravet Syndrome Receiving Concomitant Stiripentol and Valproic Acid
Vincent Jullien et al.
CLINICAL PHARMACOKINETICS (2015)
Lamotrigine can be beneficial in patients with Dravet syndrome
Linda Dalic et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2015)
Role(s) of the 5-HT2C Receptor in the Development of Maximal Dentate Activation in the Hippocampus of Anesthetized Rats
Gergely Orban et al.
CNS NEUROSCIENCE & THERAPEUTICS (2014)
Dravet syndrome-From epileptic encephalopathy to channelopathy
Andreas Brunklaus et al.
EPILEPSIA (2014)
ANTECOLLIS AND LEVODOPA-RESPONSIVE PARKINSONISM ARE LATE FEATURES OF DRAVET SYNDROME
Alfonso Fasano et al.
NEUROLOGY (2014)
Efficacy of verapamil as an adjunctive treatment in children with drug-resistant epilepsy: A pilot study
Francesco Nicita et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2014)
Stiripentol in Dravet syndrome: Results of a retrospective US study
Elaine C. Wirrell et al.
EPILEPSIA (2013)
Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy
Rima Nabbout et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment
Scott C. Baraban et al.
NATURE COMMUNICATIONS (2013)
Progressive Gait Deterioration in Adolescents With Dravet Syndrome
Jill M. Rodda et al.
ARCHIVES OF NEUROLOGY (2012)
Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome
A. Brunklaus et al.
BRAIN (2012)
Dravet syndrome: Seizure control and gait in adults with different SCN1A mutations
Jennifer J. Rilstone et al.
EPILEPSIA (2012)
Successful use of fenfluramine as an add-on treatment for Dravet syndrome
Berten Ceulemans et al.
EPILEPSIA (2012)
Electroencephalographic Features in Dravet Syndrome: Five-Year Follow-Up Study in 22 Patients
Nicola Specchio et al.
JOURNAL OF CHILD NEUROLOGY (2012)
Comorbidities and predictors of health-related quality of life in Dravet syndrome
Andreas Brunklaus et al.
EPILEPSIA (2011)
Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: A prospective pilot study
Rima Nabbout et al.
EPILEPSIA (2011)
A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: Continuous spikes and waves during sleep is definitely a target
S. Chhun et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2011)
Optogenetic Localization and Genetic Perturbation of Saccade-Generating Neurons in Zebrafish
Peter J. Schoonheim et al.
JOURNAL OF NEUROSCIENCE (2010)
Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy
Paola Iannetti et al.
EPILEPSY RESEARCH (2009)
Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals
Charles F. Dahl et al.
BMC MEDICINE (2008)
An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy
P. Striano et al.
NEUROLOGY (2007)
PTC124 targets genetic disorders caused by nonsense mutations
Ellen M. Welch et al.
NATURE (2007)
Serotonergic 5-HT2C receptors as a potential therapeutic target for the design antiepileptic drugs
M Isaac
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Clinical correlations of mutations in the SCN1A gene:: From febrile seizures to severe myoclonic epilepsy in infancy
BPGM Ceulemans et al.
PEDIATRIC NEUROLOGY (2004)
Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial
G Coppola et al.
EPILEPSY RESEARCH (2002)
De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy
L Claes et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Topiramate in the treatment of severe myoclonic epilepsy in infancy
M Nieto-Barrera et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2000)
Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial
C Chiron et al.
LANCET (2000)
分享论文
